-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 9th, Huadong Medicine issued an announcement stating that its wholly-owned subsidiary Sino-American Huadong received the "Notice of Acceptance" approved and issued by NMPA, and the application for the clinical trial of the first class new drug MB-102 injection declared by Sino-American Huadong and MediBeacon Get accepted.
MB-102 is a fluorescent tracer used to measure the glomerular filtration rate.